Catalent Inc. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
17,900.00
210,200.00
111,200.00
109,800.00
83,600.00
Depreciation, Depletion & Amortization
142,900.00
140,800.00
140,600.00
146,500.00
190,100.00
Other Funds
-
10,300.00
8,700.00
5,400.00
13,700.00
Funds from Operations
165,400.00
260,100.00
257,000.00
311,300.00
365,700.00
Changes in Working Capital
12,900.00
88,300.00
101,700.00
11,800.00
8,800.00
Net Operating Cash Flow
178,300.00
171,800.00
155,300.00
299,500.00
374,500.00
Capital Expenditures
122,400.00
141,000.00
139,600.00
139,800.00
176,500.00
Sale of Fixed Assets & Businesses
900.00
-
1,900.00
700.00
5,200.00
Net Investing Cash Flow
171,200.00
271,800.00
143,500.00
309,000.00
919,300.00
Issuance/Reduction of Debt, Net
42,300.00
742,000.00
16,300.00
166,700.00
405,000.00
Net Financing Cash Flow
42,100.00
196,500.00
25,000.00
161,300.00
669,100.00
Net Change in Cash
32,000.00
76,900.00
19,700.00
156,700.00
121,900.00
Free Cash Flow
55,900.00
30,800.00
15,700.00
159,700.00
198,000.00
Deferred Taxes & Investment Tax Credit
15,100.00
-
-
1,300.00
35,400.00
Net Assets from Acquisitions
53,700.00
130,800.00
5,800.00
169,900.00
748,000.00
Other Sources
4,000.00
-
-
-
-
Change in Capital Stock
200.00
948,800.00
-
-
277,800.00
Exchange Rate Effect
3,000.00
19,600.00
6,500.00
4,900.00
2,400.00

About Catalent

View Profile
Address
14 Schoolhouse Road
Somerset New Jersey 08873
United States
Employees -
Website http://www.catalent.com
Updated 07/08/2019
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. It operates through the following segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment focuses on the formulation, development, and manufacture of prescription and consumer health soft capsules, softgels, vegicaps and optishell capsules.